William D Haire
Affiliation: University of Nebraska Medical Center
- Pancytopenia due to iron deficiency worsened by iron infusion: a case reportApar Kishor Ganti
Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
J Med Case Reports 1:175. 2007..Much less common is the development of thrombocytopenia following replenishment of iron stores...
- Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trialWilliam D Haire
University of Nebraska Medical Center, Section of Oncology Hematology, 987680 Nebraka Medical Center, Omaha, Nebraska 68198 7680, USA
Thromb Haemost 92:575-82. 2004..In conclusion, r-UK is superior to placebo in restoring total catheter patency to occluded CVADs. In patients with occluded CVADs, intra-catheter thrombolysis can restore patency and may obviate the need for catheter replacement...
- Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosisApar Kishor Ganti
Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
J Thromb Thrombolysis 23:155-8. 2007..Management of patients with dysfibrinogenemia and a thrombotic tendency usually involves long-term anticoagulation...
- Multiple organ dysfunction syndrome in hematopoietic stem cell transplantationWilliam D Haire
Department of Internal Medicine, Section of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA
Crit Care Med 30:S257-62. 2002....
- Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trialPetr Svoboda
Intensive Care, Traumatological Hospital, Masaryk University of Brno, Czech Republic
Crit Care Med 32:1990-6. 2004..The median +/- sd time to patency was 15 +/- 20.8 mins (range, 5-203 mins). CONCLUSION: The use of a new r-UK, 5000 IU/mL, is safe and effective for the restoration of patency to occluded CVADs...
- Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolismWilliam D Haire
Curr Hematol Rep 2:405-6. 2003